A New Gene Therapy Cure Just Treated Its First-Ever Patient – Futurism
Futurism |
A New Gene Therapy Cure Just Treated Its First-Ever Patient
Futurism This March, child with severe combined immune deficiency (SCID) became the second commercial gene therapy patient ever. The patient started receiving a drug called Strimvelis from GlaxoSmithKline — a drug that appears to be able to cure the rare, … |
Science Daily |
Dual-channel biological function generator
Science Daily Rice University bioengineers who specialize in creating tools for synthetic biology have unveiled the latest version of their “biofunction generator and “bioscilloscope,” an optogenetic platform that uses light to activate and study two biological … |
Science Magazine |
Money still missing as the plan to synthesize a human genome takes another step forward
Science Magazine Others say that a made-to-order human genome is inevitable anyways, hoping to seize the publicity and controversy it creates as an opportunity to educate the public about synthetic biology. “If you put humans as the target, even though you are not … Plan to build synthetic human DNA genome gains momentumBioNews |
Oncology Nurse Advisor |
Influenza Vaccination Increases Toxicity in PD-1/PD-L1 Immunotherapy Blockade for Lung Cancer
Oncology Nurse Advisor Although seasonal influenza vaccination produced good serologic protection and no observed short-term toxicity, it was associated with increased rates of immunologic toxicity in patients with lung cancer receiving PD-1/PD-L1 immunotherapy blockade. PD-Inhibitor Benefits ‘Continue Beyond Progression’ in NSCLCMedscape Immune Checkpoint Inhibitors are Here to Stay in NSCLC, Expert SaysTargeted Oncology Checkpoint Inhibitors Improve Response to Salvage Chemotherapy in NSCLCCancer Network |